CLINICAL STUDIES OF AM-715

Abstract

2 patients with acute bronchitis, I with chronic cholangitis, 15 with UTI were treated with AM-715, ranging from 300mg to 600mg in daily doses for 5 to 15 days.
Clinical response was excellent in 7, good in 6, fair in 1 and poor in 4 patients. Bacterial effect was eradicated in 10, supressed in 2, persisted in 3. One patient complained of a transient dizziness. No significant adverse effect was noted in laboratory examination.